Senator has questions on Amgen anemia drug rebates

Reuters, April 4, 2008
Sen. Charles Grassley is questioning Amgen Inc. regarding allegations that some doctors received higher rebates on purchases of the company's anti-anemia drug Aranesp. In a statement, Grassley said there were concerns doctors were profiting by getting reimbursements from the government and private insurers that were higher than their actual cost for Aranesp. The drug is currently under scrutiny for safety concerns.

MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.